HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 277, Issue 41, 38737-38745, October 11, 2002

This Article Full Text Full Text (PDF) All Versions of this Article: 277/41/38737    most recent M201742200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gaidarova, S. Articles by Jiménez, S. A. Search for Related Content PubMed PubMed Citation Articles by Gaidarova, S. Articles by Jiménez, S. A. Social Bookmarking                      What's this?

Inhibition of Basal and Transforming Growth Factor--induced Stimulation of COL1A1 Transcription by the DNA Intercalators, Mitoxantrone and WP631, in Cultured Human Dermal Fibroblasts^*

Svetlana Gaidarova and Sergio A. Jiménez^§

From the Division of Rheumatology, Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania 19107

The Sp1 transcription factor plays a crucial role in COL1A1 transcriptional regulation under normal and pathologic conditions and under the effects of transforming growth factor- (TGF-). Sp1 activity is elevated in numerous diseases characterized by tissue fibrosis. Therefore, inhibition of Sp1 binding to COL1A1 regulatory elements may represent an effective treatment for these diseases. Here we examined the effect of two DNA intercalators that prevent Sp1 binding on the expression of COL1A1 in human dermal fibroblasts. Cultured human adult dermal fibroblasts were treated with WP631 (50 pM/ml to 500 nM/ml) or mitoxantrone (5-500 nM/ml). Cytotoxicity, cellular apoptosis, and collagen deposition were examined by fluorescence microscopy. Collagen production was examined by enzyme-linked immunosorbent assay and metabolic labeling, COL1A1 steady-state mRNA levels, and stability were assessed by Northern hybridizations, and COL1A1 transcription by in vitro nuclear transcription assays and transient transfections. Competition of the drugs for Sp1 binding and their effect on TGF--induced stimulation of COL1A1 transcription was also examined. Both drugs caused a dose-related inhibition of COL1A1 production and mRNA levels without cytotoxicity or apoptosis. COL1A1 transcriptional activity showed a profound reduction mediated by a short proximal promoter region containing an Sp1-binding element at 87 to 82 bp. Furthermore, both drugs inhibited Sp1 DNA complex formation and abrogated the stimulation of COL1A1 transcription induced by TGF-. WP631 showed 10-fold higher potency than mitoxantrone. These data indicate that mitoxantrone and WP631 are very potent inhibitors of basal and TGF--stimulated COL1A1 expression and suggest that Sp1-DNA intercalators may be an effective and novel approach for the treatment of fibrotic diseases and modulation of profibrogenic effects of TGF-.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				M. Kypriotou, G. Beauchef, C. Chadjichristos, R. Widom, E. Renard, S. A. Jimenez, J. Korn, F.-X. Maquart, T. Oddos, O. Von Stetten, et al. Human Collagen Krox Up-regulates Type I Collagen Expression in Normal and Scleroderma Fibroblasts through Interaction with Sp1 and Sp3 Transcription Factors J. Biol. Chem., November 2, 2007; 282(44): 32000 - 32014. [Abstract] [Full Text] [PDF]

				N Sandorfi, N Louneva, E Hitraya, G Hajnoczky, B Saitta, and S A Jimenez Inhibition of collagen gene expression in systemic sclerosis dermal fibroblasts by mithramycin Ann Rheum Dis, December 1, 2005; 64(12): 1685 - 1691. [Abstract] [Full Text] [PDF]

				K. Bein, E. T. Odell-Fiddler, and M. Drinane Role of TGF-{beta}1 and JNK signaling in capillary tube patterning Am J Physiol Cell Physiol, October 1, 2004; 287(4): C1012 - C1022. [Abstract] [Full Text] [PDF]

				O. Stuve, M. Kita, D. Pelletier, R. J Fox, J. Stone, D. E Goodkin, and S. S Zamvil Mitoxantrone as a potential therapy for primary progressive multiple sclerosis Multiple Sclerosis, May 1, 2004; 10(3_suppl): S58 - S61. [Abstract] [PDF]

				S. A. Jimenez and C. T. Derk Following the Molecular Pathways toward an Understanding of the Pathogenesis of Systemic Sclerosis Ann Intern Med, January 6, 2004; 140(1): 37 - 50. [Full Text] [PDF]

				N. Louneva, B. Saitta, D. J. Herrick, and S. A. Jimenez Transcriptional Inhibition of Type I Collagen Gene Expression in Scleroderma Fibroblasts by the Antineoplastic Drug Ecteinascidin 743 J. Biol. Chem., October 10, 2003; 278(41): 40400 - 40407. [Abstract] [Full Text] [PDF]